Genetic Selection for Critical Residues in Ribonucleases

Journal of Molecular Biology

Volumn 362, Issue 3, 2006, Pages 459-478

  Smith, Bryan D ^a   Raines, Ronald T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

angiogenin; error prone PCR; genetic selection; molecular evolution; ribonuclease A

Indexed keywords

AMINO ACID; ANGIOGENIN; RIBONUCLEASE; RIBONUCLEASE A;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC SELECTION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SEQUENCE HOMOLOGY;

BOS TAURUS; MAMMALIA;

EID: 33748108375     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.07.020     Document Type: Article

References (133)

1. Perutz M.F., Kendrew J.C., and Watson H.C. Structure and function of haemoglobin II. Some relations between polypeptide chain configuration and amino acid sequence. J. Mol. Biol. 13 (1965) 669-678
2. Chothia C., and Lesk A.M. The relation between the divergence of sequence and structure in proteins. EMBO J. 5 (1986) 823-826
3. Loeb D.D., Swanstrom R., Everitt L., Manchester M., Stamper S.E., and Hutchison III C.A. Complete mutagenesis of the HIV-1 protease. Nature 340 (1989) 397-400
4. Bowie J.U., and Sauer R.T. Identifying determinants of folding and activity for a protein of unknown structure. Proc. Natl Acad. Sci. USA 86 (1989) 2152-2156
5. Bowie J.U., Reidhaar-Olson J.F., Lim W.A., and Sauer R.T. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science 247 (1990) 1306-1310
6. Rennell D., Bouvier S.E., Hardy L.W., and Poteete A.R. Systematic mutation of bacteriophage T4 lysozyme. J. Mol. Biol. 222 (1991) 67-88
7. Poteete A.R., Rennell D., and Bouvier S.E. Functional significance of conserved amino acid residues. Proteins: Struct. Funct. Genet. 13 (1992) 38-40
8. Markiewicz P., Kleina L.G., Cruz C., Ehret S., and Miller J.H. Genetic studies of the lac repressor. XIV. Analysis of 4000 altered Escherichia coli lac repressors reveals essential and non-essential residues, as well as "spacers" which do not require a specific sequence. J. Mol. Biol. 240 (1994) 421-433
9. Suckow J., Markiewicz P., Kleina L.G., Miller J., Kisters-Woike B., and Muller-Hill B. Genetic studies of the lac repressor. XV. 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure. J. Mol. Biol. 261 (1996) 509-523
10. Axe D.D., Foster N.W., and Fersht A.R. Active barnase variants with completely random hydrophobic cores. Proc. Natl Acad. Sci. USA 93 (1996) 5590-5594
11. Axe D.D., Foster N.W., and Fersht A.R. A search for single substitutions that eliminate enzymatic function in a bacterial ribonuclease. Biochemistry 37 (1998) 7157-7166
12. Guo H.H., Choe J., and Loeb L.A. Protein tolerance to random amino acid change. Proc. Natl Acad. Sci. USA 101 (2004) 9205-9210
13. Campbell-Valois F.X., Tarassov K., and Michnick S.W. Massive sequence perturbation of a small protein. Proc. Natl Acad. Sci. USA 102 (2005) 14988-14993
14. Sela M., White Jr. F.H., and Anfinsen C.B. Reductive cleavage of disulfide bridges in ribonuclease. Science 125 (1957) 691-692
15. Anfinsen C.B. Principles that govern the folding of protein chains. Science 181 (1973) 223-230
16. Barnard E.A. Ribonucleases. Annu. Rev. Biochem. 38 (1969) 677-732
17. Richards F.M., and Wyckoff H.W. Bovine pancreatic ribonuclease. The Enzymes vol. 4 (1971) 647-806
18. Karpeisky M.Y., and Yakovlev G.I. Topochemical principles of the substrate specificity of nucleases. Sov. Sci. Rev. sect. D 2 (1981) 145-257
19. Blackburn P., and Moore S. Pancreatic ribonuclease. The Enzymes vol. 15 (1982) 317-433
20. Wlodawer A. Structure of bovine pancreatic ribonuclease by X-ray and neutron diffraction. In: Jurnak F.A., and McPherson A. (Eds). Biological Macromolecules and Assemblies. Nucleic Acids and Interactive Proteins vol. II (1985), Wiley, New York 395-439
21. Eftink M.R., and Biltonen R.L. Pancreatic ribonuclease A: the most studied endoribonuclease. In: Neuberger A., and Brocklehurst K. (Eds). Hydrolytic Enzymes (1987), Elsevier, New York 333-375
22. Beintema J.J. Structure, properties and molecular evolution of pancreatic-type ribonucleases. Life Chem. Rep. 4 (1987) 333-389
23. Beintema J.J., Schüller C., Irie M., and Carsana A. Molecular evolution of the ribonuclease superfamily. Prog. Biophys. Mol. Biol. 51 (1988) 165-192
24. In: D'Alessio G., and Riordan J.F. (Eds). Ribonucleases: Structures and Functions (1997), Academic Press, New York
25. Raines R.T. Ribonuclease A. Chem. Rev. 98 (1998) 1045-1065
26. Wedemeyer W.J., Welker E., Narayan M., and Scheraga H.A. Disulfide bonds and protein folding. Biochemistry 39 (2000) 4207-4216
27. Chatani E., and Hayashi R. Functional and structural roles of constituent amino acid residues of bovine pancreatic ribonuclease A. J. Biosci. Bioeng. 92 (2001) 98-107
28. Raines R.T. Active site of ribonuclease A. In: Zenkova M.A. (Ed). Artificial Nucleases (2004), Springer-Verlag, Heidelberg, Germany 19-32
29. Beintema J.J., and Kleineidam R.G. The ribonuclease A superfamily: general discussion. Cell. Mol. Life Sci. 54 (1998) 825-832
30. Leonidas D.D., Chavali G.B., Oikonomakos N.G., Chrysina E.D., Kosmopoulou M.N., Vlassi M., et al. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhbitors. Implications for structure-based design of ribonucleolytic inhibitors. Protein Sci. 12 (2003) 2559-2574
31. Schein C.H. From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases. Nature Biotechnol. 15 (1997) 529-536
32. Leland P.A., and Raines R.T. Cancer chemotherapy-Ribonucleases to the rescue. Chem. Biol. 8 (2001) 405-425
33. Matoušek J. Ribonucleases and their antitumor activity. Comp. Biochem. Physiol. 129C (2001) 175-191
34. Loverix S., and Steyaert J. Ribonucleases: from prototypes to therapeutic targets?. Curr. Med. Chem. 10 (2003) 779-785
35. Makarov A.A., and Ilinskaya O.N. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Letters 540 (2003) 15-20
36. Strydom D.J., Fett J.W., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., and Vallee B.L. Amino acid sequence of human tumor derived angiogenin. Biochemistry 24 (1985) 5486-5494
37. Riordan J.F. Structure and function of angiogenin. In: D'Alessio G., and Riordan J.F. (Eds). Ribonucleases: Structures and Functions (1997), Academic Press, New York 445-489
38. Strydom D.J. The angiogenins. Cell. Mol. Life Sci. 54 (1998) 811-824
39. Badet J. Angiogenin, a potent mediator of angiogenesis. Biological, biochemical and structural properties. Pathol. Biol. 47 (1999) 345-351
40. Shapiro R., Fox E.A., and Riordan J.F. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry 28 (1989) 1726-1732
41. Shapiro R., and Vallee B.L. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry 28 (1989) 7401-7408
42. Xu Z.P., Tsuji T., Riordan J.F., and Hu G.F. Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42 (2003) 121-128
43. Hooper L.V., Stappenbeck T.S., Hong C.V., and Gordon J.I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunol. 4 (2003) 269-273
44. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nature Genet. 38 (2006) 411-413
45. Woycechowsky K.J., and Hilvert D. Deciphering enzymes. Genetic selection as a probe of structure and mechanism. Eur. J. Biochem. 271 (2004) 1630-1637
46. Dower W.J., Miller J.F., and Ragsdale C.W. High efficiency transformation of E. coli by high voltage electroporation. Nucl. Acids Res. 16 (1988) 6127-6145
47. delCardayré S.B., Ribó M., Yokel E.M., Quirk D.J., Rutter W.J., and Raines R.T. Engineering ribonuclease A: production, purification, and characterization of wild-type enzyme and mutants at Gln11. Protein Eng. 8 (1995) 261-273
48. Derman A.I., Prinz W.A., Belin D., and Beckwith J. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 262 (1993) 1744-1747
49. Prinz W.A., Åslund F., Holmgren A., and Beckwith J. The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J. Biol. Chem. 272 (1997) 15661-15667
50. Bessette P.H., Aslund F., Beckwith J., and Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl Acad. Sci. USA 96 (1999) 13703-13708
51. Messmore J.M., Fuchs D.N., and Raines R.T. Ribonuclease A: revealing structure-function relationships with semisynthesis. J. Am. Chem. Soc. 117 (1995) 8057-8060
52. Thompson J.E., and Raines R.T. Value of general acid-base catalysis to ribonuclease A. J. Am. Chem. Soc. 116 (1994) 5467-5468
53. Leland P.A., Staniszewski K.E., Park C., Kelemen B.R., and Raines R.T. The ribonucleolytic activity of angiogenin. Biochemistry 41 (2002) 1343-1350
54. St. Clair D.K., Rybak S.M., Riordan J.F., and Vallee B.L. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes. Proc. Natl Acad. Sci. USA 84 (1987) 8330-8334
55. St. Clair D.K., Rybak S.M., Riordan J.F., and Vallee B.L. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes. Biochemistry 27 (1988) 7263-7268
56. Shapiro R., Riordan J.F., and Vallee B.L. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25 (1986) 3527-3532
57. St Clair D.K., Rybak S.M., Riordan J.F., and Vallee B.L. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes. Proc. Natl Acad. Sci. USA 84 (1987) 8330-8334
58. Schimmel P. Hazards and their exploitation in the applications of molecular biology to structure-function relationships. Biochemistry 29 (1990) 9495-9502
59. Fujii S., Akiyama M., Aoki K., Sugaya Y., Higuchi K., Hiraoka M., et al. DNA replication errors produced by the replicative apparatus of Escherichia coli. J. Mol. Biol. 289 (1999) 835-850
60. Hermes J.D., Blacklow S.C., and Knowles J.R. Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme. Proc. Natl Acad. Sci. USA 87 (1990) 696-700
61. Rowe L.A., Geddie M.L., Alexander O.B., and Matsumura I. A comparison of directed evolution approaches using the β-glucuronidase model system. J. Mol. Biol. 332 (2003) 851-860
62. Neylon C. Chemical and biochemical strategies for the randomization of protein encoding DNA sequences: library construction methods for directed evolution. Nucl. Acids Res. 32 (2004) 1448-1459
63. Vanhercke T., Ampe C., Tirry L., and Denolf P. Reducing mutational bias in random protein libraries. Anal. Biochem. 339 (2005) 9-14
64. Cline J., and Hogrefe H. Randomize gene sequences with new PCR mutagenesis kit. Strategies Newsletter 13 (2000) 157-162
65. Ganguly T., Chen P., Teetsel R., Zhang L.P., Papaioannou E., and Cianciarulo J. High-throughput sequencing of high copy number plasmids from bacterial cultures by heat lysis. Biotechniques 39 (2005) 304-308
66. Dickson K.A., Haigis M.C., and Raines R.T. Ribonuclease inhibitor: structure and function. Prog. Nucl. Acid Res. Mol. Biol. 80 (2005) 349-374
67. Acharya K.R., Shapiro R., Allen S.C., Riordan J.F., and Vallee B.L. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc. Natl Acad. Sci. USA 91 (1994) 2915-2919
68. Findlay D., Herries D.G., Mathias A.P., Rabin B.R., and Ross C.A. The active site and mechanism of action of bovine pancreatic ribonuclease. Nature 190 (1961) 781-784
69. Findlay D., Mathias A.P., and Rabin B.R. The active site and mechanism of action of bovine pancreatic ribonuclease. 7. The catalytic mechanism. Biochem. J. 85 (1962) 139-144
70. Crestfield A.M., Stein W.H., and Moore S. Alkylation and identification of the histidine residues at the active site of ribonuclease. J. Biol. Chem. 238 (1963) 2413-2419
71. Cuchillo C.M., Vilanova M., and Nogués M.V. Pancreatic ribonucleases. In: D'Alessio G., and Riordan J.F. (Eds). Ribonucleases: Structures and Functions (1997), Academic Press, New York 271-304
72. Park C., Schultz L.W., and Raines R.T. Contribution of the active site histidine residues of ribonuclease A to nucleic acid binding. Biochemistry 40 (2001) 4949-4956
73. Messmore J.M., and Raines R.T. Pentavalent organo-vanadates as transition state analogues for phosphoryl transfer reactions. J. Am. Chem. Soc. 122 (2000) 9911-9916
74. Thompson J.E., Kutateladze T.G., Schuster M.C., Venegas F.D., Messmore J.M., and Raines R.T. Limits to catalysis by ribonuclease A. Bioorg. Chem. 23 (1995) 471-481
75. Lenstra J.A., Hofsteenge J., and Beintema J.J. Invariant features of the structure of pancreatic ribonuclease. A test of different predictive models. J. Mol. Biol. 109 (1977) 185-193
76. Kolbanovskaya E.Y., Sathyanarayana B.K., Wlodawer A., and Karpeisky M.Y. Intramolecular interactions in pancreatic ribonucleases. Protein Sci. 1 (1992) 1050-1060
77. Kolbanovskaya E.Y., Morozov N.Y., Gavryushov S.A., Ilin V.A., Beintema J.J., Wlodawer A., and Karpeisky M.Y. Structural-functional analysis of ribonuclease A and related proteins. Mol. Biol. 27 (1993) 821-836
78. Chatani E., Nonomura K., Hayashi R., Balny C., and Lange R. Comparison of heat- and pressure-induced unfolding of ribonuclease A: the critical role of Phe46 which appears to belong to a new hydrophobic chain-folding initiation site. Biochemistry 41 (2002) 4567-4574
79. Matheson R.R., and Scheraga H.A. Method for predicting nucleation sites for protein folding based on hydrophobic contacts. Macromolecules 11 (1978) 819-829
80. Matheson R.R., and Scheraga H.A. Steps in the pathway of the thermal unfolding of ribonuclease A. A nonspecific photo-chemical surface-labeling study. Biochemistry 18 (1979) 2437-2445
81. Montelione G.T., and Scheraga H.A. Formation of local structures in protein folding. Acc. Chem. Res. 22 (1989) 70-76
82. Balaji S., Aruna S., and Srinivasan N. Tolerance to the substitution of buried apolar residues by charged residues in the homologous protein structures. Proteins: Struct. Funct. Genet. 53 (2003) 783-791
83. +. Biopolymers 29 (1990) 1-11
84. Navon A., Ittah V., Laity J.H., Scheraga H.A., Haas E., and Gussakovsky E.E. Local and long-range interactions in the thermal unfolding transition of bovine pancreatic ribonuclease A. Biochemistry 40 (2001) 93-104
85. Ratnaparkhi G.S., and Varadarajan R. Thermodynamic and structural studies of cavity formation in proteins suggest that loss of packing interactions rather than the hydrophobic effect dominates the observed energetics. Biochemistry 39 (2000) 12365-12374
86. Gutte B. Synthetic 63-residue RNase A analogs. Simultaneous exchange of asparagine 44 by leucine and of threonine 45 by valine. J. Biol. Chem. 253 (1978) 3837-3842
87. Kadonosono T., Chatani E., Hayashi R., Moriyama H., and Ueki T. Minimization of cavity size ensures protein stability and folding: structures of Phe46-replaced bovine pancreatic RNase A. Biochemistry 42 (2003) 10651-10658
88. Markert Y., Köditz J., Vriend G., Mansfeld J., Arnold U., and Ulbrich-Hofmann R. Increased proteolytic resistance of ribonuclease A by protein engineering. Protein Eng. 14 (2001) 791-796
89. Torrent J., Connelly J.P., Coll M.G., Ribo M., Lange R., and Vilanova M. Pressure versus heat-induced unfolding of ribonuclease A: the case of hydrophobic interactions within a chain-folding initiation site. Biochemistry 38 (1999) 15952-15961
90. Torrent J., Rubens P., Ribo M., Heremans K., and Vilanova M. Pressure versus temperature unfolding of ribonuclease A: an FTIR spectroscopic characterization of 10 variants at the carboxy-terminal site. Protein Sci. 10 (2001) 725-734
91. Coll M.G., Protasevich I.I., Torrent J., Ribo M., Lobachov V.M., Makarov A.A., and Vilanova M. Valine 108, a chain-folding initiation site-belonging residue, crucial for the ribonuclease A stability. Biochem. Biophys. Res. Commun. 265 (1999) 356-360
92. Eberhardt E.S., Wittmayer P.K., Templer B.M., and Raines R.T. Contribution of a tyrosine side chain to ribonuclease A catalysis and stability. Protein Sci. 5 (1996) 1697-1703
93. Holloway D.E., Chavali G.B., Hares M.C., Subramanian V., and Acharya K.R. Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies. Acta Crystallog. sect. D 61 (2005) 1568-1578
94. Leu Y.J., Chern S.S., Wang S.C., Hsiao Y.Y., Amiraslanov I., Liaw Y.C., and Liao Y.D. Residues involved in the catalysis, base specificity, and cytotoxicity of ribonuclease from Rana catesbeiana based upon mutagenesis and X-ray crystallography. J. Biol. Chem. 278 (2003) 7300-7309
95. Tanimizu N., Ueno H., and Hayashi R. Role of Phe120 in the activity and structure of bovine pancreatic ribonuclease A. J. Biochem. (Tokyo) 124 (1998) 410-416
96. Klink T.A., Woycechowsky K.J., Taylor K.M., and Raines R.T. Contribution of disulfide bonds to the conformational stability and catalytic activity of ribonuclease A. Eur. J. Biochem. 267 (2000) 566-572
97. Laity J.H., Shimotakahara S., and Scheraga H.A. Expression of wild-type and mutant bovine pancreatic ribonuclease A in Escherichia coli. Proc. Natl Acad. Sci. USA 90 (1993) 615-619
98. Pearson M.A., Karplus P.A., Dodge R.W., Laity J.H., and Scheraga H.A. Crystal structures of two mutants that have implications for the folding of bovine pancreatic ribonuclease A. Protein Sci. 7 (1998) 1255-1258
99. Shin H.C., Narayan M., Song M.C., and Scheraga H.A. Role of the [65-72] disulfide bond in oxidative folding of bovine pancreatic ribonuclease A. Biochemistry 42 (2003) 11514-11519
100. Mikulski S.M., Costanzi J.J., Vogelzang N.J., McCachren S., Taub R.N., Chun H., et al. Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma. J. Clin. Oncol. 20 (2002) 274-281
101. Leland P.A., Schultz L.W., Kim B.-M., and Raines R.T. Ribonuclease A variants with potent cytotoxic activity. Proc. Natl Acad. Sci. USA 98 (1998) 10407-10412
102. Leland P.A., Staniszewski K.E., Kim B.-M., and Raines R.T. Endowing human pancreatic ribonuclease with toxicity for cancer cells. J. Biol. Chem. 276 (2001) 43095-43102
103. Kim J.-S., Souèek J., Matoušek J., and Raines R.T. Catalytic activity of bovine seminal ribonuclease is essential for its immunosuppressive and other biological activities. Biochem. J. 308 (1995) 547-550
104. Rutkoski T.J., Kurten E.L., Mitchell J.C., and Raines R.T. Disruption of shape-complementarity markers to create cytotoxic variants of ribonuclease A. J. Mol. Biol. 354 (2005) 41-54
105. Harper J.W., and Vallee B.L. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry 28 (1989) 1875-1884
106. Raines R.T., Toscano M.P., Nierengarten D.M., Ha J.H., and Auerbach R. Replacing a surface loop endows ribonuclease A with angiogenic activity. J. Biol. Chem. 270 (1995) 17180-17184
107. Curran T.P., Shapiro R., and Riordan J.F. Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Biochemistry 32 (1993) 2307-2313
108. delCardayré S.B., and Raines R.T. Structural determinants of enzymatic processivity. Biochemistry 33 (1994) 6031-6037
109. delCardayré S.B., and Raines R.T. A residue to residue hydrogen bond mediates the nucleotide specificity of ribonuclease A. J. Mol. Biol. 252 (1995) 328-336
110. Kelemen B.R., Schultz L.W., Sweeney R.Y., and Raines R.T. Excavating an active site: the nucleobase specificity of ribonuclease A. Biochemistry 39 (2000) 14487-14494
111. Dodge R.W., and Scheraga H.A. Folding and unfolding kinetics of the proline-to-alanine mutants of bovine pancreatic ribonuclease A. Biochemistry 35 (1996) 1548-1559
112. Juminaga D., Wedemeyer W.J., and Scheraga H.A. Proline isomerization in bovine pancreatic ribonuclease A. 1. Unfolding conditions. Biochemistry 37 (1998) 11614-11620
113. Russo N., Acharya K.R., Vallee B.L., and Shapiro R. A combined kinetic and modeling study of the catalytic center subsites of human angiogenin. Proc. Natl Acad. Sci. USA 93 (1996) 804-808
114. Shapiro R., Harper J.W., Fox E.A., Jansen H.W., Hein F., and Uhlmann E. Expression of Met-(-1) angiogenin in Escherichia coli: conversion to the authentic
115. Notomista E., Catanzano F., Graziano G., Dal Piaz F., Barone G., D'Alessio G., and Di Donato A. Onconase: an unusually stable protein. Biochemistry 39 (2000) 8711-8718
116. Shapiro R., and Vallee B.L. Identification of functional arginines in human angiogenin by site-directed mutagenesis. Biochemistry 31 (1992) 12477-12485
117. Hammes G.G. Multiple conformational changes in enzyme catalysis. Biochemistry 41 (2002) 8221-8228
118. Leland P.A., Staniszewski K.E., Kim B., and Raines R.T. A synapomorphic disulfide bond is critical for the conformational stability and cytotoxicity of an amphibian ribonuclease. FEBS Letters 477 (2000) 203-207
119. Duret L., Mouchiroud D., and Gouy M. HOVERGEN: a database of homologous vertebrate genes. Nucl. Acids Res. 22 (1994) 2360-2365
120. Futami J., Tada H., Seno M., Ishikami S., and Yamada H. Stabilization of human RNase 1 by introduction of a disulfide bond between residues 4 and 118. J. Biochem. (Tokyo) 128 (2000) 245-250
121. Klink T.A., and Raines R.T. Conformational stability is a determinant of ribonuclease A cytotoxicity. J. Biol. Chem. 275 (2000) 17463-17467
122. Tarragona-Fiol A., Eggelte H.J., Harbron S., Sanchez E., Taylorson C.J., Ward J.M., and Rabin B.R. Identification by site-directed mutagenesis of amino acids in the B2 subsite of bovine pancreatic ribonuclease A. Protein Eng. 6 (1993) 901-906
123. Fontecilla-Camps J.C., de Llorens R., le Du M.H., and Cuchillo C.M. Crystal structure of ribonuclease A•d(ApTpApApG) complex. J. Biol. Chem. 269 (1994) 21526-21531
124. Schultz L.W., Quirk D.J., and Raines R.T. His⋯Asp catalytic dyad of ribonuclease A: structure and function of the wild-type, D121N, and D121A enzymes. Biochemistry 37 (1998) 8886-8898
125. Cho S., and Zhang J. Ancient expansion of the ribonuclease A superfamily revealed by genomic analysis of placental and marsupial mammals. Gene 373 (2006) 116-125
126. Cho S., Beintema J.J., and Zhang J. The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85 (2005) 208-220
127. Park S.H., and Raines R.T. Genetic selection for dissociative inhibitors of designated protein-protein interactions. Nature Biotechnol. 18 (2000) 847-851
128. Matsumura I., and Ellington A.D. Mutagenic polymerase chain reaction of protein-coding genes for in vitro evolution. Methods Mol. Biol. 182 (2002) 259-267
129. Staden R., Beal K.F., and Bonfield J.K. The Staden package, 1998. Methods Mol. Biol. 132 (2000) 115-130
130. Wlodawer A., Anders L.A., Sjölin L., and Gilliland G.L. Structure of phosphate-free ribonuclease A refined at 1.26 Å. Biochemistry 27 (1988) 2705-2717
131. Leonidas D.D., Shapiro R., Allen S.C., Subbarao G.V., Veluraja K., and Acharya K.R. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J. Mol. Biol. 285 (1999) 1209-1233
132. Collaborative Computational Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
133. Thompson J.D., Higgins D.G., and Gibson T.J. ClustalW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalities and weight matrix choice. Nucl. Acids Res. 22 (1994) 4673-4680